Tetanus vaccines: WHO position paper – February 2017
Wkly Epidemiol Rec. 2017 Feb 10;92(6):53-76.
[Article in
English,
French]
No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Anti-Bacterial Agents / therapeutic use
-
Child
-
Clostridium tetani
-
Cost-Benefit Analysis
-
Female
-
Guidelines as Topic*
-
Humans
-
Immunization, Passive
-
Immunization, Secondary
-
Incidence
-
Infant, Newborn
-
Male
-
Middle Aged
-
Population Surveillance
-
Pregnancy
-
Tetanus / diagnosis
-
Tetanus / epidemiology
-
Tetanus / immunology
-
Tetanus / therapy*
-
Tetanus Toxoid / administration & dosage*
-
Tetanus Toxoid / adverse effects
-
Tetanus Toxoid / immunology
-
World Health Organization*
-
Wounds and Injuries / complications
-
Wounds and Injuries / therapy
Substances
-
Anti-Bacterial Agents
-
Tetanus Toxoid